Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Diamandis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Cancer Research : MCR|August 10, 2010
Personalized medicine: marking a new epoch in cancer patient managementMaria Diamandis, Nicole M A White, George M Yousef
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 16, 2008
Quebec platelet disorder: features, pathogenesis and treatmentMaria Diamandis, D Kika Veljkovic, Elisabeth Maurer-Spurej, et al.
The Prostate|April 12, 2002
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissuesGeorge M Yousef, Andreas Scorilas, Albert Chang, et al.
Blood|November 26, 2008
Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiationD Kika Veljkovic, Georges E Rivard, Maria Diamandis, et al.
Blood|December 17, 2009
Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator geneAndrew D Paterson, Johanna M Rommens, Bhupinder Bharaj, et al.
Clinical Chemistry|July 27, 2002
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancerGeorge M Yousef, Andreas Scorilas, Lianna G Kyriakopoulou, et al.
Blood|November 8, 2008
Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytesMaria Diamandis, Andrew D Paterson, Johanna M Rommens, et al.
The Journal of Urology|July 26, 2011
miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulationNicole M A White, Tian Tian Bao, Jörg Grigull, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Cancer Research : MCR|August 10, 2010
Personalized medicine: marking a new epoch in cancer patient managementMaria Diamandis, Nicole M A White, George M Yousef
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 16, 2008
Quebec platelet disorder: features, pathogenesis and treatmentMaria Diamandis, D Kika Veljkovic, Elisabeth Maurer-Spurej, et al.
The Prostate|April 12, 2002
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissuesGeorge M Yousef, Andreas Scorilas, Albert Chang, et al.
Blood|November 26, 2008
Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiationD Kika Veljkovic, Georges E Rivard, Maria Diamandis, et al.
Blood|December 17, 2009
Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator geneAndrew D Paterson, Johanna M Rommens, Bhupinder Bharaj, et al.
Clinical Chemistry|July 27, 2002
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancerGeorge M Yousef, Andreas Scorilas, Lianna G Kyriakopoulou, et al.
Blood|November 8, 2008
Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytesMaria Diamandis, Andrew D Paterson, Johanna M Rommens, et al.
The Journal of Urology|July 26, 2011
miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulationNicole M A White, Tian Tian Bao, Jörg Grigull, et al.
Pageof 1